Bacterial metabolite patterns of infants receiving multi-strain probiotics and risk of late-onset sepsis.

Authors

Silvio Waschina, Julia Pagel, Karsten Seeger, Elisa Pasderski, Malte Rühlemann, Sina Froitzheim, Sven Künzel, Felix Sommer, Sören Franzenburg, Ingmar Fortmann, Fumi Sugihara, Kirstin Faust, Janina Marissen, Martin Demmert, John F Baines, Wolfgang Göpel, Egbert Herting, Christoph Kaleta, Jan Rupp, Christoph Härtel

Year of publication

2025

Journal

CELL REP

Volume

44

Issue

11

ISSN

2211-1247

Impact factor

7.5

Abstract

The effect of multi-strain probiotics containing Bifidobacterium longum (B. longum) on late-onset sepsis (LOS) risk in very-low-birth-weight infants (VLBWIs; birth weight < 1,500 g) remains uncertain. In a single-center study, we analyzed intestinal metagenome and metabolome data in VLBWIs during the period of highest vulnerability of LOS. Using a unit's policy change to routinely administer B. longum subspecies infantis plus Lactobacillus acidophilus as natural experiment, we compared 97 infants (including 38 LOS cases) after change with 78 infants (including 32 LOS cases) before. Probiotic supplementation was associated with more beneficial bacteria and reduced abundance of nosocomial pathobionts, such as Klebsiella spp. Infants in the probiotic group had significantly lower concentrations of B. longum fermentation products prior to sepsis diagnosis than matched non-LOS cases (acetate: padj = 0.0049; lactate: padj = 0.048). Modulation of the gut metabolic milieu is an interesting target for LOS prevention.